Breil Yao,Group SC Director of Xiangxue pharmaceutical

发布时间:2019-05-09
Lecture topic: Pharmaceutical Company Production Management

20190227.jpg

Breil Yao, Group Supply Chain Director, Xiangxue pharmaceutical Co., Ltd

Lecture topic: Pharmaceutical Company Production Management

Resume

Breil Yao is currently the Group SC Director of Xiangxue pharmaceutical Co., Ltd. from Jul 2002 to Mar 2010, he took several positions from Engineer to Senior Supervisor in engineering in Hangzhou MSD pharmaceutical Co. Ltd.; From Mar 2010 to Aug 2018, he took the position as Maintenance Manager/Senior Maintenance Manager, Associate Engineering Director (west lake plant), and was certified as Six Sigma Black Belt in Lilly Suzhou pharmaceutical Co. Ltd.; And from Sep 2018 to Feb 2019, he took the position as a senior advisor in Suzhou Costar Pharmaeng Co., Ltd.

He graduated from Zhejiang University with bachelor degree of Mechanical Engineering in July 2002; and earned MBA of Zhejiang University from Sep 2005 to Mar 2011; He was certified as Black Belt of ASQ (American Society of Quality) in march, 2016; and was certified in Production & Inventory Management(CPIM) of APICS (American Production and Inventory Control Society) in Sep 2018.

Presentation Summary

There are two trends in Chinese pharmaceutical industry, one is from unique plant to multi-plant and another is practice learning from multinational company. This course will introduce production practice of pharmaceutical plant for the two trends.

Plant management: what is general organization structure for pharmaceutical plant? What is the role and responsibility of each department? How to manage the plant through all levels of meeting and KPI review? How to define KPI? What is PT/FT and how it operates efficiently?

Corporate production management: how to plan and manage each site? Management system is same as plant but with different focus.

Special management: there are three special managements in pharmaceutical plant which are validation, product control strategy and MAH. Validation is a lifecycle process but not only 4Qs. Product control strategy starts from R&D to production, how to define and control product quality in the process? MAH is popular recently and there is dedicated chapter to introduce it in updated drug management regulation.

 

0
-1
收藏
评论